We are live on ! Find out more
AFC

Ares Financial Consulting Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
+$12.1M
Cap. Flow
+$897K
Cap. Flow %
0.64%
Top 10 Hldgs %
40.89%
Holding
1,171
New
105
Increased
235
Reduced
84
Closed
39
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARI
976
Apollo Commercial Real Estate
ARI
$875M
$1.2K ﹤0.01%
112
BWA icon
977
BorgWarner
BWA
$13.7B
$1.2K ﹤0.01%
18
ATYR
978
aTyr Pharma
ATYR
$48.2M
$1.19K ﹤0.01%
2,000
ASH icon
979
Ashland
ASH
$3.29B
$1.19K ﹤0.01%
18
VLGEA icon
980
Village Super Market
VLGEA
$637M
$1.18K ﹤0.01%
28
GPI icon
981
Group 1 Automotive
GPI
$3.25B
$1.17K ﹤0.01%
4
DJT icon
982
Trump Media & Technology Group
DJT
$2.72B
$1.16K ﹤0.01%
150
MLM icon
983
Martin Marietta Materials
MLM
$32.5B
$1.15K ﹤0.01%
+2
New +$1.19K
UVV icon
984
Universal Corp
UVV
$1.32B
$1.15K ﹤0.01%
22
CLX icon
985
Clorox
CLX
$12.8B
$1.15K ﹤0.01%
12
-35
-74% -$3.36K
G icon
986
Genpact
G
$6.1B
$1.14K ﹤0.01%
42
+1
+2% +$33
UGP icon
987
Ultrapar
UGP
$6.83B
$1.12K ﹤0.01%
224
HWC icon
988
Hancock Whitney
HWC
$6.26B
$1.12K ﹤0.01%
15
MKC icon
989
McCormick & Company Non-Voting
MKC
$13.9B
$1.11K ﹤0.01%
22
DRH icon
990
Diamondrock Hospitality Co
DRH
$2.6B
$1.11K ﹤0.01%
91
CNQ icon
991
Canadian Natural Resources
CNQ
$94.6B
$1.11K ﹤0.01%
28
MDLN
992
Medline Inc
MDLN
$29.7B
$1.1K ﹤0.01%
+28
New +$1.13K
CSL icon
993
Carlisle Companies
CSL
$15.4B
$1.09K ﹤0.01%
+3
New +$1.05K
CROX icon
994
Crocs
CROX
$6.5B
$1.09K ﹤0.01%
9
NOK icon
995
Nokia
NOK
$52.9B
$1.08K ﹤0.01%
81
AIZ icon
996
Assurant
AIZ
$14.6B
$1.07K ﹤0.01%
4
GPCR icon
997
Structure Therapeutics
GPCR
$3.67B
$1.07K ﹤0.01%
+20
New +$885
ONON icon
998
On Holding
ONON
$12.5B
$1.06K ﹤0.01%
30
CRUS icon
999
Cirrus Logic
CRUS
$6.07B
$1.04K ﹤0.01%
7
HLX icon
1000
Helix Energy Solutions
HLX
$1.47B
$1.04K ﹤0.01%
119

Similar funds

Ares Financial Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, Ares Financial Consulting held 1,171 positions worth $139M, up 9.5% from $127M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ares Financial Consulting's Q2 2026 filing shows 105 new, 235 increased, 84 reduced and 39 closed positions. Its largest new stake was AstraZeneca: 486 shares worth $92.2K. The largest sale was Dimensional US Core Equity Market ETF, an estimated $443K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Communication Services and Industrials.

  • Ares Financial Consulting's largest Q2 2026 buy was AstraZeneca: 486 shares worth $92.2K.
  • Ares Financial Consulting added most to PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2026, an estimated $567K increase.
  • Ares Financial Consulting's biggest Q2 2026 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $443K.
  • Ares Financial Consulting fully exited Vanguard FTSE All-World ex-US ETF in Q2 2026, selling an estimated $203K.
  • Ares Financial Consulting's ten largest holdings make up 41% of its $139M portfolio in Q2 2026.
  • Ares Financial Consulting opened 105 new positions and closed 39 in Q2 2026.
  • Ares Financial Consulting's portfolio value rose 9.5% quarter-over-quarter to $139M.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.